BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7073416)

  • 1. Serum thyroglobulin in the management of patients with thyroid cancer.
    Barsano CP; Skosey C; DeGroot LJ; Refetoff S
    Arch Intern Med; 1982 Apr; 142(4):763-7. PubMed ID: 7073416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complementary role of whole body scan and serum thyroglobulin determination in the follow-up of differentiated thyroid carcinoma.
    Ronga G; Fiorentino A; Fragasso G; Fringuelli FM; Todino V
    Ital J Surg Sci; 1986; 16(1):11-5. PubMed ID: 3087907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of patients with differentiated thyroid cancer who have positive serum thyroglobulin levels and negative radioiodine scans.
    Clark OH; Hoelting T
    Thyroid; 1994; 4(4):501-5. PubMed ID: 7711516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can iodine-131 whole-body scan be replaced by thyroglobulin measurement in the post-surgical follow-up of differentiated thyroid carcinoma?
    Ronga G; Fiorentino A; Paserio E; Signore A; Todino V; Tummarello MA; Filesi M; Baschieri I
    J Nucl Med; 1990 Nov; 31(11):1766-71. PubMed ID: 2121913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum thyroglobulin in the management of thyroid cancer.
    Blahd WH
    J Nucl Med; 1990 Nov; 31(11):1771-3. PubMed ID: 2121914
    [No Abstract]   [Full Text] [Related]  

  • 6. Follow-up study of postoperative patients with thyroid cancer by thallium-201 scintigraphy and serum thyroglobulin measurement.
    Iida Y; Hidaka A; Hatabu H; Kasagi K; Konishi J
    J Nucl Med; 1991 Nov; 32(11):2098-100. PubMed ID: 1941144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation.
    Rosario PW; Mineiro Filho AF; Lacerda RX; dos Santos DA; Calsolari MR
    Thyroid; 2012 Feb; 22(2):113-6. PubMed ID: 22224815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated serum thyroglobulin. A marker of metastases in differentiated thyroid carcinomas.
    Herle AJ; Uller RP
    J Clin Invest; 1975 Aug; 56(2):272-7. PubMed ID: 1150869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [131I-accumulating pulmonary and bone metastases of differentiated thyroid cancer with low serum thyroglobulin levels--an exception in tumor follow-up?].
    Arning G; Ehrenheim C; Schober O; Hundeshagen H
    Nuklearmedizin; 1987 Jun; 26(3):139-42. PubMed ID: 3628022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum thyroglobulin, a monitor of differentiated thyroid carcinoma in patients receiving thyroid hormone suppression therapy: concise communication.
    Blahd WH; Drickman MV; Porter CW; Hill VA; Baumgartner WA
    J Nucl Med; 1984 Jun; 25(6):673-6. PubMed ID: 6726444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevalence of iodine- and thyroglobulin-negative findings in differentiated thyroid cancer.A retrospective analysis of patients treated from 1951 to 1998 in university hospital].
    Klutmann S; Jenicke L; Geiss-Tönshoff M; Bohuslavizki KH; Mester J; Clausen M
    Nuklearmedizin; 2001 Oct; 40(5):143-7. PubMed ID: 11727626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroglobulin measurements in the follow-up of patients with differentiated thyroid carcinoma: comparison with quantitative radioactive iodine uptake measurements and total body scans.
    Bolk JH; Bussemaker JK; Nieuwenhuijzen Kruseman AC; De Vijlder JJ; Goslings BM
    Neth J Med; 1985; 28(9):340-6. PubMed ID: 4047268
    [No Abstract]   [Full Text] [Related]  

  • 13. Thyroglobulin monitoring after treatment of well-differentiated thyroid cancer.
    Hamy A; Mirallié E; Bennouna J; Resche I; Drefty C; Johnstone M; Visset J
    Eur J Surg Oncol; 2004 Aug; 30(6):681-5. PubMed ID: 15256244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioiodine total body scan versus serum thyroglobulin levels in follow-up of patients with thyroid cancer.
    Colacchio TA; LoGerfo P; Colacchio DA; Feind C
    Surgery; 1982 Jan; 91(1):42-5. PubMed ID: 7034259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of thyroglobulin positive/whole-body scan negative: is Tg positive/131I therapy useful?
    McDougall IR
    J Endocrinol Invest; 2001 Mar; 24(3):194-8. PubMed ID: 11314751
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum thyroglobulin levels predict total body iodine scan findings in patients with treated well-differentiated thyroid carcinoma.
    Charles MA; Dodson LE; Waldeck N; Hofeldt F; Ghaed N; Telepak R; Ownbey J; Burstein P
    Am J Med; 1980 Sep; 69(3):401-7. PubMed ID: 7416187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal, in thyroid cancer patients.
    Baudin E; Do Cao C; Cailleux AF; Leboulleux S; Travagli JP; Schlumberger M
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1107-11. PubMed ID: 12629092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of serum thyroglobulin assays in cancers of the thyroid].
    Schlumberger M; Fragu P; Travagli JP; Gardet P; Lumbroso J; Charbord P; Lacour J; Parmentier C
    Nouv Presse Med; 1982 Oct; 11(42):3101-5. PubMed ID: 7177824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer.
    Ozata M; Suzuki S; Miyamoto T; Liu RT; Fierro-Renoy F; DeGroot LJ
    J Clin Endocrinol Metab; 1994 Jul; 79(1):98-105. PubMed ID: 8027262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical evaluation of serum thyroglobulin levels and I-131 scans in post-therapy patients with differentiated thyroid carcinoma: concise communication.
    Echenique RL; Kasi L; Haynie TP; Glenn HJ; Samaan NA; Hill CS
    J Nucl Med; 1982 Mar; 23(3):235-40. PubMed ID: 7062137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.